Daily Journal Staff Writer
CARLSBAD — In its November quarterly filing, Ionis Pharmaceuticals Inc. noted, "Our success depends to a significant degree upon whether we can continue to develop and secure intellectual property rights to proprietary products and services."
That makes Patrick R. O'Neil a very busy man.
Ionis' drugs target different areas of the body than tr... (continued)